Latest filing published 19 Sept 2025 for Jacobio Pharmaceuticals Group Co., Ltd. - B, €960k. Read the official filing
Based on 26 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Wang Xiaojie in Jacobio Pharmaceuticals Group Co., Ltd. - B. We count 37 filings; the first trade dates from 21 December 2020 and the latest from 18 September 2025.
In open-market terms, that means 26 purchases worth €21.0M on one side and 8 sales worth €38.9M on the other. The totals exclude 3 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2025 to date brings 11 purchases and 2 sales.
A typical purchase (the median) is worth €40k. On 26 out of 26 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 26 purchases with a full 90-day history, the hit rate stands at 27% and the median 90-day move at -10.3%. This is a record of the past, not a forecast.
The latest filing, published on 19 September 2025, reports an open-market sale of €960k in Jacobio Pharmaceuticals Group Co., Ltd. - B. The clock since the last published purchase (5 September 2025) now reads 411 days. Typically, a trade is published a median of 3 days after it takes place. That lag is the time during which only the insider knows about the trade. Source: insider filings from HKEX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 37 declarations